Ratings Acumentis Group Limited Australian S.E.

Equities

LMW

AU0000058687

End-of-day quote Australian S.E. 5-day change 1st Jan Change
- AUD -.--% Intraday chart for Acumentis Group Limited -6.67% -6.67%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The firm trades with high earnings multiples: 22 times its 2024 earnings per share.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Gold

1st Jan change Capi. Investor Rating ESG Refinitiv
-6.67% 1.4B -
+14.44% 23.6B
B+
+18.12% 15.6B
B
+34.04% 8.93B
C+
+40.67% 5.54B
C
-2.15% 5.21B
A-
+2.27% 5.25B
C+
+26.93% 3.29B
C+
-6.45% 2.36B
A-
+19.82% 2.31B
D+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. EMR Stock
  4. LMW Stock
  5. Ratings Acumentis Group Limited